These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9296920)

  • 1. [The use of low doses of sodium aurothiomalate in the treatment of rheumatoid arthritis. Current trends in basic therapy].
    Bianucci G; Maddali Bongi S; Cencetti A; Curradi C
    Clin Ter; 1996 Dec; 147(12):609-20. PubMed ID: 9296920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presence of HLA-DRB1 alleles in a group of patients with rheumatoid arthritis treated with low doses of sodium aurothiomalate].
    Bianucci G; Rombolà G; Tringali M; Curradi C; Bongi SM
    Clin Ter; 1997 Dec; 148(12):577-92. PubMed ID: 9528193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
    van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR
    J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined drug therapy in recent-onset rheumatoid arthritis. Evaluation after 1 year of treatment].
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Zeminian S; Bambara LM
    Recenti Prog Med; 1998 Jan; 89(1):14-7. PubMed ID: 9549387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of parenteral gold preparations on heart function in rheumatoid arthritis patients (based on echocardiographic data)].
    Nemchinov EN; Chichasova NV; Kanevskaia MZ; Slobodina GA
    Revmatologiia (Mosk); 1989; (4):23-8. PubMed ID: 2576902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M; Kaneda K
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases.
    Ujfalussy I; Koó E; Seszták M; Gergely P
    Z Rheumatol; 2003 Apr; 62(2):155-60. PubMed ID: 12721703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
    Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
    Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
    Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
    J Rheumatol; 2003 Aug; 30(8):1748-55. PubMed ID: 12913930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
    Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects of gold salt therapy in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
    J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.